SAMSUNG PHARM. Co., LTD. (KOSE:A001360) announced that it has issued series 31 bearer book non-guaranteed private equity convertible bonds for gross proceeds of KRW 21,700,000,000 on February 14, 2020. The bonds have a yield to maturity rate of 2% and maturity date on February 14, 2023. The bonds are 100% convertible into 4,794,520 shares for 8.13% stake at KRW 4,526 per share. The conversion period starts from February 14, 2021 and ends on January 14, 2023. The transaction has been approved by the board of directors of the company. The transaction involved participation from Kiwoom Investment Co., Ltd. for KRW 3,000,000,000, Sangsangin Plus Savings Bank Co.,Ltd. for KRW 2,000,000,000, Sangsang Saving Bank for KRW 1,000,000,000, Ian Ok for KRW 2,000,000,000, Lee Un Kyung for KRW 1,500,000,000, Jae Won Choi for KRW 1,100,000,000, Lee Myung-sun for KRW 1,000,000,000, Sook Young Jung for KRW 1,000,000,000, Poetry for KRW 1,000,000,000, Nas Equity for KRW 900,000,000, freshness for KRW 600,000,000, Huncheol Lee for KRW 500,000,000, Garden seat for KRW 500,000,000, Tae Joon Byun for KRW 500,000,000, Ryu Byung-hee for KRW 500,000,000, Lee Yeon-ok for KRW 500,000,000, Young Wook Kwon for KRW 500,000,000, Remake Asset for KRW 400,000,000, Kwak Eunkyung for KRW 300,000,000, Jeon Jeon for KRW 300,000,000, Reason for KRW 300,000,000, Beomju Kim for KRW 300,000,000, In Kook Kim for KRW 300,000,000, Arira for KRW 300,000,000, Sungbok Kim for KRW 300,000,000, Hyunhee for KRW 200,000,000, Soo-Yum Um for KRW 200,000,000, Taehoon Kim for KRW 200,000,000, Moonhyun for KRW 200,000,000, Pil Soon Choi for KRW 200,000,000, and Youngmi Nam for KRW 100,000,000.